Clinical Trials Logo

Colorectal Neoplasm clinical trials

View clinical trials related to Colorectal Neoplasm.

Filter by:

NCT ID: NCT02510911 Terminated - Diverticulitis Clinical Trials

Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?

CaCo
Start date: August 2015
Phase: N/A
Study type: Interventional

Postoperative bowel paralysis is common after abdominal operations, including colectomy. As a result, hospitalization may be prolonged leading to increased cost. A recent randomized controlled trial from the University of Heidelberg showed that consumption of regular black coffee after colectomy is safe and associated with a significantly faster resumption of intestinal motility (Müller 2012). The mechanism how coffee stimulates intestinal motility is unknown but caffeine seems to be the most likely stimulating agent. Thus, this trial addresses the question: Does caffeine reduce postoperative bowel paralysis after elective laparoscopic colectomy? Patients after laparoscopic colectomy will receive either 100 mg caffeine, 200 mg caffeine, or 250mg corn starch (placebo) 3 times daily in identically looking gelatin capsules. The study is a randomized, controlled trial, with blinding of physicians, patients and nursing stuff (evaluating the endpoints). Primary endpoint will be the time to first bowel movement.

NCT ID: NCT02384850 Terminated - Colorectal Neoplasm Clinical Trials

Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer

SENTINEL
Start date: March 2015
Phase: Phase 1
Study type: Interventional

This trial will evaluate the combination treatment of established chemotherapy regimen mFOLFOX6 with Selinexor, an oral Selective Inhibitor Of Nuclear Export, in patients with metastatic Colorectal Cancer. The purpose is to determine the maximum tolerated dose (MTD) of selinexor in combination with mFOLFOX6.

NCT ID: NCT02324556 Terminated - Colorectal Neoplasm Clinical Trials

A LAparoscopic and TransAnal Total Mesorectal Excision (TME) for Rectal Cancer Trial

LATA
Start date: January 2015
Phase:
Study type: Observational

All patients planned for an anterior resection due to rectal cancer with a total mesorectal excision are included. This is a feasibility study, thus no randomization will be performed. Primary endpoint is clinical and pathologic examination of the specimen. Secondary end-points include clinical variables such as conversion rate, re-admission and/or re-operation due to any complication and health economy analyses.

NCT ID: NCT02244632 Completed - Colorectal Neoplasm Clinical Trials

Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

Start date: September 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose is to characterise the tolerability of Modufolin (arfolitixorin) in combination with 5-FU alone, in combination with 5-FU and Oxaliplatin, in combination with 5-FU and Irinotecan and in combination with 5-FU, Oxaliplatin and Bevacizumab. Another purpose is to investigate 4 doses of Modufolin to identify the best dose for further assessment.

NCT ID: NCT02121405 Suspended - Surgery Clinical Trials

Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM

PSSR
Start date: October 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether primary radiotherapy can be omitted for the locally advanced rectal cancer with Magnetic Resonance Imaging (MRI) negative circumferential margin.

NCT ID: NCT02057471 Completed - Anemia Clinical Trials

Intravenous Iron: Measuring Response in Anemic Surgical Patients

Start date: September 2009
Phase: Phase 4
Study type: Interventional

20 Patients will be recruited with confirmed colorectal adenocarcinoma and anemia who are planned to undergo surgery. All patients will be treated with a single dose of 1g intravenous ferric carboxymaltose (FERINJECT). It is hypothesized that intravenous iron supplementation is efficacious at raising haemoglobin levels and reduced blood transfusion requirements.

NCT ID: NCT01959269 Completed - Colorectal Neoplasm Clinical Trials

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy

RECORA
Start date: October 31, 2013
Phase: N/A
Study type: Observational

The purpose of the study is to investigate the safety and effectiveness of Stivarga in patients with metastatic colorectal carcinoma in routine use in Germany. The study is purely observational, only data from routine treatment are to be collected. The treatment and treatment conditions are solely at discretion of the treating physician.

NCT ID: NCT01707121 Completed - Physical Activity Clinical Trials

The Impact of Physical Activity on the Outcome of Surgery

Start date: December 2012
Phase: N/A
Study type: Observational

Over the last decades different life style factors have been established as risk factors for various diseases. The obesity pandemic displays a good example of a disease where great effort is undertaken to characterize risk factors associated with obesity (1). Smoking is another life style risk factor established since several decades, and where primary prevention has been increasingly successful (2, 3). Cardiovascular epidemiologic research at the University of Gothenburg recognized PA as a factor of importance early on and thus included PA related questions in the work up of studies with large cohorts (4-6). A 4-level scale was introduced in the late 1960:s by Saltin and Grimby (7) and has been used extensively since then. With this background it is of interest to record physical activity one year and one month prior to certain types of elective surgery and to study the relationship of PA to surgical complications and recovery is of interest. The aim of this study is to investigate whether a higher physical activity prior to a surgical procedure reduces hospital stay, sick leave and the complication rate. A secondary aim is to investigate the effect of preoperative physical activity on the rate of resumption of QoL and normal physical function.

NCT ID: NCT01701310 Completed - Anemia Clinical Trials

IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia

IVICA
Start date: April 2012
Phase: Phase 4
Study type: Interventional

116 eligible patients with confirmed non-metastatic colorectal adenocarcinoma and anemia will be randomized to receive either oral ferrous sulphate (control) or intravenous ferric carboxymaltose (intervention). It is hypothesized that intravenous iron supplementation is more efficacious than oral iron therapy.

NCT ID: NCT01694238 Completed - Diverticulitis Clinical Trials

A Randomized Trial on the Technical Aspects of Stoma Construction.

Start date: June 2013
Phase: N/A
Study type: Interventional

An investigation on the difference in stoma hernia frequency related to surgical technique when incising the fascia. All patients planned for elective colostomy formation are to be included. Patients undergoing rectal resection with a TME and a colostomy (Hartmann's procedure) for rectal cancer, abdominoperineal resection for rectal cancer or diverting colostomy for any reason are all included. The three groups for randomization are: A. circular incision in the abdominal wall fascia B. cruciate incision in the abdominal wall fascia C. mesh enforced cruciate incision in the abdominal wall fascia Primary endpoint is the parastomal hernia rate within 12 months from index surgery. Secondary end-points include clinical variables, re-admission and/or re-operation due to any stoma complication, quality of life and health economy analyses, at 12 months.